RedHill Biopharma Ltd.
METHOD FOR TREATING CANCER WITH COMBINATION THERAPY
Last updated:
Abstract:
Provided are methods for treating cancer in a patient by administering at least one antibiotic selected from the group consisting of clofazimine, rifabutin and clarithromycin, in combination with an aryladamantane compound. In an embodiment, the aryladamantane compound is [3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide], or a pharmaceutically acceptable salt thereof.
Status:
Application
Type:
Utility
Filling date:
17 Sep 2019
Issue date:
16 Apr 2020